Feb 21, 2017 13:01 pm UTC| Business
Top-line results are expected in the second quarter of 2017Therandomized, double-blind, placebo-controlledPhase III study is evaluating the safety and efficacy of BEKINDA®24 mg in patients with acute gastroenteritis and...
Feb 21, 2017 13:01 pm UTC| Business
Top-line results are expected in the second quarter of 2017Therandomized, double-blind, placebo-controlledPhase III study is evaluating the safety and efficacy of BEKINDA®24 mg in patients with acute gastroenteritis and...
Feb 21, 2017 13:01 pm UTC| Business
NEW YORK, Feb. 21, 2017 -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that a retrospective, multicenter study...
Feb 21, 2017 13:01 pm UTC| Business
NEW YORK, Feb. 21, 2017 -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that a retrospective, multicenter study...
3D Signatures to Present Positive Results for Prostate Cancer Liquid Biopsy
Feb 21, 2017 13:01 pm UTC| Business
WINNIPEG, Manitoba, Feb. 21, 2017 -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that later today Dr. Sabine Mai, its co-founder and principle inventor, will...
3D Signatures to Present Positive Results for Prostate Cancer Liquid Biopsy
Feb 21, 2017 13:01 pm UTC| Business
WINNIPEG, Manitoba, Feb. 21, 2017 -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that later today Dr. Sabine Mai, its co-founder and principle inventor, will...
Farmer Bros. Co. Announces New Sales Model to Strengthen DSD Organization
Feb 21, 2017 13:01 pm UTC| Business
Restructure Expected to Better Serve Customers and Improve Sales Growth Targeted Annual Savings of $2.0 Million - $2.6 Million Estimated Pre-Tax Restructuring Charges of $3.7 Million - $4.9 Million NORTHLAKE, Texas,...